Home › Funds › Kynam Capital Management, LP › TRAW

Kynam Capital Management, LP position in TRAW

TRAWS PHARMA INC · Health Care

Kynam Capital Management, LP reported holding 84,400 shares of TRAW (TRAWS PHARMA INC) in its Q3 2026 13F filing — a position valued at US$50K, representing 0.00% of its reported portfolio and ranking #34 among its reported holdings. Kynam Capital Management, LP has disclosed TRAW holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)84.40K sh
Reported value held$50.12K
Portfolio Weight0.00%
First reportedQ2 2026
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Kynam Capital Management, LP's TRAW position evolved

Kynam Capital Management, LP first disclosed a stake in TRAW in Q2 2026 at 84,400 shares (US$71K). Across 2 filings, Kynam Capital Management, LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 84,400 shares valued at US$50K.

Quarter by quarter

QuarterSharesValueChange
Q2 2026 84.40K $71.17K New
Q3 2026 84.40K $50.12K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TRAW and 13F data

TRAW (TRAWS PHARMA INC) is a Health Care company. 32 other funds we track also report a position in TRAW — the largest reported positions include Ally Bridge Group (NY) LLC (US$663K), Lynx1 Capital Management LP (US$472K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TRAW

All TRAW fund holders →

FAQ

How long has Kynam Capital Management, LP held TRAW?

Kynam Capital Management, LP has disclosed TRAW holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Kynam Capital Management, LP's current position in TRAW?

As of Q3 2026, Kynam Capital Management, LP holds 84.40K shares of TRAW (TRAWS PHARMA INC), valued at $50.12K, representing 0.00% of its reported portfolio and ranking #34.

Has Kynam Capital Management, LP been buying or selling TRAW?

In the latest 13F filing (Q3 2026), Kynam Capital Management, LP held unchanged its position in TRAW.

Which other funds hold TRAW?

Other major institutional holders of TRAW include Ally Bridge Group (NY) LLC, Lynx1 Capital Management LP, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.